LI
LENNOX INTERNATIONAL INC (LII)·Q4 2024 Earnings Summary
Executive Summary
- Q4 2024 delivered strong operational results: revenue $1.345B (+16% YoY; core +22%), operating income $245M (+32%), operating margin 18.2% (+220 bps), GAAP EPS $5.52 and adjusted EPS $5.60 (+54% YoY) .
- Management attributed outsized Q4 strength to R‑410A prebuy ahead of the 2025 refrigerant transition (estimated +$125M revenue and +$1.00 EPS), pricing/mix, and factory productivity; they cautioned this will be a headwind to Q1 and create tough comps in Q4 2025 .
- Segment performance was bifurcated: Home Comfort Solutions (HCS) revenue $887M (+25%) with margin up 550 bps to 21.7%; Building Climate Solutions (BCS) revenue $458M (+17%) with margin down 160 bps to 21.6% from new factory ramp and inefficiencies .
- FY2025 guidance: core revenue ~+2%, adjusted EPS $22.00–$23.50, capex ~$150M, FCF $650–$800M; net debt/adjusted EBITDA at 0.6x provides balance sheet flexibility. Investor focus centers on prebuy unwind, 454B pricing realization, and BCS productivity benefits in 2H25 .
- Additional Q4-period items: quarterly dividend declared at $1.15 (payable Jan 15, 2025) and inclusion in the S&P 500 in December 2024 .
What Went Well and What Went Wrong
What Went Well
- Record profitability and margins: operating income reached $245M and adjusted segment margin expanded 250 bps to 18.4%, with management highlighting “record achievements” and improved cash conversion .
- HCS outperformance from volume leverage, pricing excellence, and factory/product cost tailwinds; HCS margin rose 550 bps to 21.7% with notable growth in the 2‑step distributor channel .
- Cash generation surged: Q4 operating cash flow $332M and FCF $273M (+50% YoY), with CFO citing 97% FCF conversion and net debt/adjusted EBITDA down to 0.6x .
What Went Wrong
- BCS margin pressure from new factory ramp-up and existing facility inefficiencies (~$20M cost), despite revenue +17% and segment profit +9% .
- 2024 R‑410A prebuy creates transitory headwinds: pull-forward into Q4 will weigh on 1H25 (especially Q1), and Q4 2025 comps will be tougher; management emphasized uncertainty across rates, tariffs, and labor .
- Corporate expense increased $13M YoY (adjusted), and inflation remains a 3% cost headwind (SG&A notably pressured), muting margin expansion assumptions in guidance .
Financial Results
Consolidated Summary
Notes:
- Adjusted EPS reconciliation differences in Q4 2024 were minimal vs GAAP (loss on sale from previous dispositions ~$3.1M after tax) .
- Sequential revenue and margin declines vs Q3 reflect normal seasonality plus prebuy dynamics management flagged in Q&A .
Segment Breakdown
KPIs and Cash Deployment
Guidance Changes
FY2024 actuals vs Q3 raised guidance for context:
- FY2024 revenue $5.341B vs prior guide ~+10% revenue (qualitative), GAAP/adjusted EPS $22.54/$22.58 vs guide $20.75–$21.00, FCF $785M vs guide $575–$650M .
Earnings Call Themes & Trends
Management Commentary
- CEO: “2024 was a remarkable year filled with record achievements… We successfully navigated the complex product transition to the new refrigerant while maintaining a disciplined approach to M&A.”
- CFO: “We are pleased to report our eighth consecutive quarter of double-digit year-over-year adjusted EPS growth… customers prepurchased R‑410A equipment, which is estimated to have positively impacted revenue by $125 million and increased earnings per share by $1.”
- CEO on priorities: Focus on digital customer experience, expanded heat pump offering (Samsung JV), parts/accessories attachment rates, and commercial emergency replacement to drive resilient margins and growth into 2026 .
- CFO on capital deployment: “Free cash flow conversion rate of 97%… net debt to adjusted EBITDA at 0.6x… capex estimated at $150M in 2025; FCF $650–$800M.”
Q&A Highlights
- Prebuy dynamics: ~$125M revenue and ~$1 EPS pulled into Q4; majority impacts Q1 (some into Q2); also creates tough comps in Q4 2025, with benefit normalizing in Q1 2026 .
- 454B pricing: ~10% average increase on new products; with ~70% of HCS revenue converting over the year, yielding mid-single-digit mix uplift; visibility expected mid-to-late Q2 .
- BCS trajectory: Mid-single-digit volume growth with 1–2 points share gain from Saltillo; margin expansion weighted to 2H25 as ramp costs subside and productivity improves .
- Inflation and costs: 3% inflation across ~$4B cost base, heavier in SG&A (healthcare, wages); pricing/mix and productivity expected to offset, with overall margins ~flat in FY25 .
- Tariffs and supply chain: Reduced exposure to China (e.g., mini-splits via Samsung Korea) positions LII favorably if China tariffs rise; potential Mexico tariffs would be offset primarily by pricing short term and by production shifts longer term .
Estimates Context
- S&P Global consensus estimates for Q4 2024 (EPS, Revenue, EBITDA, Target Price, Recommendation) were unavailable due to a data access limit on retrieval at this time. As a result, we cannot quantify beats/misses vs Street for Q4 2024 and have anchored narrative on company-reported actuals and management commentary [GetEstimates attempt error].
Note: Wall Street consensus via S&P Global was unavailable at the time of analysis due to request limits; future updates should recheck SPGI access.
Key Takeaways for Investors
- Transitory prebuy tailwind boosted Q4; expect a payback in 1H25 (Q1 most acute) and a tough Q4 2025 comp, followed by normalization into Q1 2026—position sizing around these inflection points is prudent .
- Pricing realization on 454B (~10%) and mix uplift should support HCS margins in 2H25 as 410A sell-through concludes by Q2; monitor mid-Q2 for visibility on competitive pricing behavior .
- BCS margin expansion is a 2H25 story as Saltillo productivity ramps and inefficiencies abate; emergency replacement initiative is a meaningful share gain lever into peak season (Q2–Q3) .
- Cash conversion and balance sheet strength (0.6x net debt/EBITDA) create flexibility for opportunistic buybacks and disciplined M&A; expect capex > depreciation again in 2025, still supporting mid/high-80s FCF conversion .
- FY2025 guide implies relatively flat margins (~19.4%) amid 3% cost inflation and specific $25M SG&A investments; upside could come from lower inflation or better HCS volume if rates decline .
- Dividends remain supported ($1.15 quarterly) alongside S&P 500 inclusion, which may broaden the investor base and index demand through 2025 .
- Without confirmed Street consensus, trading should focus on the narrative—prebuy unwind trajectory, 454B pricing adherence, and BCS productivity ramp—as near-term catalysts.
Citations: